<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Three Stocks Estimated To Be Trading Below Intrinsic Value By Up To 34.7 Percent</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Three Stocks Estimated To Be Trading Below Intrinsic Value By Up To 34.7 Percent</h1>
  <ul>
<li>The company recently became profitable, reporting a net income of US$35 million for Q2 2025.</li>
<li>Revenue growth is projected at 15.2% annually, outpacing the broader US market's forecasted growth rate.</li>
<li>Estimated Discount To Fair Value: 24.9% Grab Holdings is trading at US$6, below its estimated fair value of US$7.99, suggesting potential undervaluation based on cash flows.</li>
<li>Top 10 Undervalued Stocks Based On Cash Flows In The United States | Name | Current Price | Fair Value (Est) | Discount (Est) | | Phibro Animal Health (PAHC) | $39.62 | $77.67 | 49% | | Peapack-Gladstone Financial (PGC)</li>
<li>However, its return on equity is expected to remain low at 9.6% in three years despite strong earnings growth projections of 37.5% annually.</li>
<li>Operations: The company's revenue segments include Mobility at $1.13 billion, Deliveries at $1.64 billion, and Financial Services at $297 million.</li>
<li>Eli Lilly Overview: Eli Lilly and Company discovers, develops, and markets human pharmaceuticals globally, with a market cap of $678.14 billion.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/three-stocks-estimated-trading-below-113810824.html">Source</a> · 2025-09-15T11:38:10+00:00</p>
</body>
</html>